|
|
 |
|
Viewing report
|
|
|
|
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q2, 2011
GlobalData, May 2011, Pages: 82
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q2, 2011
Summary
GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q2, 2011' provides data on the Attention Deficit Hyperactivity Disorder (ADHD) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Attention Deficit Hyperactivity Disorder (ADHD). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Brain Infarction . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
|
|
|
